BREAKING: Takeda Pharma (TSE:4502) trades 6.7% OVERVALUED at ¥5,614 despite 28.4% quarterly surge 📈 - EXCLUSIVE Feb 16 data shows analysts split (¥4,500-¥5,900 targets). Reddit investors demand proof of "60% upside" claims as fair value line breaks. Is this the top? Full analysis 🔽 [Link] #Takeda #PharmaStocks #Valuation #Investing #JapanStocks

🔗 Full Story: https://www.talknation.site/2026/02/assessing-takeda-pharmaceutical-tse4502.html

#news #tech #talknation

🏢 Takeda is hiring a Research Scientist, AI/ML Foundational Models
Location: 🇺🇸 Boston, Massachusetts, United States
💲 Salary: $111800 - $175670

#DataScience #DataScientist #tech #JobSearch #GetFediHired #HashyJobs #US #Takeda

https://datasciencejobs.com/jobs/scientist-aiml-takeda-united-states-2/

Research Scientist, AI/ML Foundational Models at Takeda, Massachusetts, United States

Unlock your next machine learning role at DataScienceJobs.com. Join Takeda as a Research Scientist, AI/ML Foundational Models in Massachusetts, United States. Don't miss out, apply for success today!

Takeda Pharmaceutical announced that its oral psoriasis drug zasocitinib proved safe and effective in late-stage trials, marking a milestone in its effort to treat the incurable skin condition. https://www.japantimes.co.jp/news/2025/12/18/japan/takeda-psoriasis-pill-ai/?utm_medium=Social&utm_source=mastodon #japan #medicine #ai #takeda
Takeda’s psoriasis pill developed with AI assistance succeeds in trials

If approved, zasocitinib would stand out as one of the first drugs discovered with the help of artificial intelligence.

The Japan Times
Takeda’s dengue vaccine has demonstrated strong protection against infection and hospitalization for seven years, marking the longest efficacy reported among any available dengue vaccines. https://www.japantimes.co.jp/business/2025/11/04/companies/takeda-dengue-vaccine/?utm_medium=Social&utm_source=mastodon #business #companies #takeda #pharmaceuticals #health #denguefever #vaccinations
Takeda’s dengue vaccine shows long-lasting protection

The results bolster confidence in Takeda’s two-dose regimen, especially as countries grapple with record dengue outbreaks fueled by climate change.

The Japan Times
タケダのワクチンへの取り組み 新型コロナワクチンの情報は「コロナ情報館」|武田薬品工業株式会社【公式】 https://www.yayafa.com/2568162/ #biopharmaceutical #business #Future #global #Health #Introduction #Medicine #Mission #People #pharmaceutical #Philosophy #Rd #Takeda #TakedaIsm #values #Vision #新型コロナウイルスで
Takeda Pharmaceutical’s experimental narcolepsy drug has significantly improved outcome for patients in late-stage clinical trials, and could become the first treatment to target the disorder's root cause. https://www.japantimes.co.jp/news/2025/09/09/japan/science-health/takeda-narcolepsy/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #takeda #health #pharmaceuticals #sleep
Takeda nears first therapy for root cause of narcolepsy

Patients who took the drug, called oveporexton, for 12 weeks experienced increased daytime alertness and an overall improvement in quality of life.

The Japan Times
📌 Más recursos: cancergrace.org/forum
Agradecemos a nuestros patrocinadores por hacerlo posible: #janssen #takeda #genentech #bms #daiichisankyo